Phathom Pharmaceuticals, Inc. - stock earnings
PHAT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -43.2 million USD | ? USD |
| 2023Q2 | -41.0 million USD | ? USD |
| 2023Q1 | -37.7 million USD | ? USD |
| 2022Q4 | -63.5 million USD | ? USD |
| 2022Q3 | -59.7 million USD | ? USD |
| 2022Q2 | -56.5 million USD | ? USD |
| 2022Q1 | -43.4 million USD | ? USD |
| 2021Q4 | -35.8 million USD | ? USD |
| 2021Q3 | -36.7 million USD | ? USD |
| 2021Q2 | -36.6 million USD | ? USD |
| 2021Q1 | -34.8 million USD | ? USD |
| 2020Q4 | -53.7 million USD | ? USD |
| 2020Q3 | -34.1 million USD | ? USD |
| 2020Q2 | -21.1 million USD | ? USD |
| 2020Q1 | -20.1 million USD | ? USD |
| 2019Q4 | -98.0 million USD | ? USD |
| 2019Q3 | -68.1 million USD | ? USD |
| 2019Q2 | -87.8 million USD | ? USD |
| 2019Q1 | -1.3 million USD | ? USD |
| 2018Q4 | -484000 USD | ? USD |
| 2018Q3 | -290000 USD | ? USD |
PHAT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -177.1 million USD | ? USD |
| 2022 | -223.0 million USD | ? USD |
| 2021 | -148.1 million USD | ? USD |
| 2020 | -133.3 million USD | ? USD |
| 2019 | -209.7 million USD | ? USD |
| 2018 | -1.3 million USD | ? USD |
PHAT
Price: $10.04
52 week price:
Earnings Per Share: -3.93 USD
P/E Ratio: -1.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 521200
Market Capitalization: 612.3 million